Bajaj Healthcare gets exclusive rights to manufacture, market Magnesium L Threonate in India

17 Jan 2025 Evaluate

Bajaj Healthcare has received exclusive rights for manufacturing, distribution & sales of the finished formulation of the Product Magnesium L Threonate (Magtein) in India from the rights holder, Threotech LLC.

The company will therefore have the rights to manufacture/ market/ distribute/co-market in the Indian market for Magnesium L Threonate (Magtein). The Company is already supplying the API Magnesium L Threonate (Magtein), to the patent holder in United States of America.

The API is supplied by Bajaj Healthcare for the brand Magtein in the United States of America as an exclusive arrangement. The brand Magtein by Threotech LLC has a sales value of around $438 million.

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.

Bajaj Healthcare Share Price

418.60 -5.35 (-1.26%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×